NCT02523287
- Conditions
- Safety Markers of Adjuvanted Influenza Vaccine
- Locations
-
- Center for Vaccinology Ghent, East-Flanders, Belgium
Clinical trial condition
Explore clinical trials studying Safety Markers of Adjuvanted Influenza Vaccine. Study availability and eligibility vary by location and protocol.
NCT02523287